Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
作者信息
Maxwell D R, Benjamin D M, Donahay S L, Allen M K, Hamburger R J, Luft F C, Kleit S A
出版信息
Proc Clin Dial Transplant Forum. 1977;7:166-9.
PMID:210446
Abstract
摘要
相似文献
1
Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.1,25-二羟维生素D3用于透析患者的随机双盲研究。
Proc Clin Dial Transplant Forum. 1977;7:166-9.
2
Calcitriol in dialysis patients.透析患者中的骨化三醇
Clin Pharmacol Ther. 1978 May;23(5):515-9. doi: 10.1002/cpt1978235515.
3
1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.1,25-二羟胆钙化醇在慢性透析中的作用。一项双盲对照研究。
Ann Intern Med. 1978 Jun;88(6):774-80. doi: 10.7326/0003-4819-88-6-774.
4
Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.1,25-二羟维生素D3与24,25-二羟维生素D3在肾性骨营养不良长期治疗中的比较
Proc Eur Dial Transplant Assoc. 1980;17:543-7.
5
Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
Contrib Nephrol. 1980;18:72-81. doi: 10.1159/000403274.
6
Use of 1,25(OH)2-vitamin D3 in prevention of renal osteodystrophy: preliminary observations.
Contrib Nephrol. 1980;18:147-51. doi: 10.1159/000403282.
7
Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
Ann Intern Med. 1981 Mar;94(3):404-5. doi: 10.7326/0003-4819-94-3-404.
8
Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.1,25(OH)₂D₃在肾性骨营养不良管理中的应用现状
Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154.
9
The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.1α(OH)D3和1α,25(OH)2D3对肾性骨营养不良患者骨骼的影响。
Am J Med. 1978 Jan;64(1):101-7. doi: 10.1016/0002-9343(78)90184-5.
10
The action of 1,25 (OH)2D3 on turnover kinetic, remodelling surfaces and structure of trabecular bone in chronic renal failure.1,25（OH）₂D₃对慢性肾衰竭患者小梁骨转换动力学、重塑表面及结构的作用
Contrib Nephrol. 1980;18:105-21. doi: 10.1159/000403278.
Zotero 插件